INDOFARM2024-10-012024-12-31 INDOFARM2024-10-012024-12-31 INDOFARM2024-10-012024-12-31in-bse-fin:OneOperatingExpenses01Member INDOFARM2024-10-012024-12-31in-bse-fin:FourOperatingExpenses01Member INDOFARM2024-12-31 INDOFARM2024-10-012024-12-31in-bse-fin:OneReportableSegmentRevenue01Member INDOFARM2024-10-012024-12-31in-bse-fin:OneReportableSegmentRevenue02Member INDOFARM2024-10-012024-12-31in-bse-fin:OneReportableSegmentRevenue03Member INDOFARM2024-10-012024-12-31in-bse-fin:OneReportableSegmentRevenue04Member INDOFARM2024-10-012024-12-31in-bse-fin:FourReportableSegmentRevenue01Member INDOFARM2024-10-012024-12-31in-bse-fin:FourReportableSegmentRevenue02Member INDOFARM2024-10-012024-12-31in-bse-fin:FourReportableSegmentRevenue03Member INDOFARM2024-10-012024-12-31in-bse-fin:FourReportableSegmentRevenue04Member INDOFARM2024-10-012024-12-31in-bse-fin:OneReportableSegmentResults01Member INDOFARM2024-10-012024-12-31in-bse-fin:OneReportableSegmentResults02Member INDOFARM2024-10-012024-12-31in-bse-fin:OneReportableSegmentResults03Member INDOFARM2024-10-012024-12-31in-bse-fin:OneReportableSegmentResults04Member INDOFARM2024-10-012024-12-31in-bse-fin:FourReportableSegmentResults01Member INDOFARM2024-10-012024-12-31in-bse-fin:FourReportableSegmentResults02Member INDOFARM2024-10-012024-12-31in-bse-fin:FourReportableSegmentResults03Member INDOFARM2024-10-012024-12-31in-bse-fin:FourReportableSegmentResults04Member INDOFARM2024-10-012024-12-31in-bse-fin:OneReportableSegmentAssets01Member INDOFARM2024-10-012024-12-31in-bse-fin:OneReportableSegmentAssets02Member INDOFARM2024-10-012024-12-31in-bse-fin:OneReportableSegmentAssets03Member INDOFARM2024-10-012024-12-31in-bse-fin:OneReportableSegmentAssets04Member INDOFARM2024-10-012024-12-31in-bse-fin:OneReportableSegmentLiabilities01Member INDOFARM2024-12-31in-bse-fin:OneReportableSegmentLiabilities01Member INDOFARM2024-10-012024-12-31in-bse-fin:OneReportableSegmentLiabilities02Member INDOFARM2024-12-31in-bse-fin:OneReportableSegmentLiabilities02Member INDOFARM2024-10-012024-12-31in-bse-fin:OneReportableSegmentLiabilities03Member INDOFARM2024-12-31in-bse-fin:OneReportableSegmentLiabilities03Member INDOFARM2024-10-012024-12-31in-bse-fin:OneReportableSegmentLiabilities04Member INDOFARM2024-12-31in-bse-fin:OneReportableSegmentLiabilities04Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 544328 INDOFARM NOTLISTED Indo Farm Equipment Limited Equity 2024-04-01 2025-03-31 2025-02-13 2025-02-07 INR Lakhs Third quarter 15:15:00 16:00:00 2025-02-13 2025-02-13 Not applicable Multi segment 2024-10-01 2024-12-31 Unaudited Consolidated 961683000.00 1354000.00 963037000.00 578060000.00 0.00 -35701000.00 123737000.00 65293000.00 27511000.00 147222000.00 906122000.00 56915000.00 0.00 56915000.00 16675000.00 422000.00 17097000.00 0.00 39818000.00 0.00 0.00 0.00 0.00 39818000.00 -16000.00 39803000.00 39818000.00 0.00 39803000.00 0.00 394516000.00 10 1.02 1.02 0.00 0.00 1.02 1.02 1 The above un-audited (Standalone and consolidated) financial results were reviewed and recommended by the Audit Committee on 13th February 2025 and approved by the Board of Directors in their meeting held on 13th February 2025. The unaudited consolidated financial results for the current quarter have been subjected to limited review by the Statutory Auditors of the Company. 2.The Statutory Auditors of the Company have expressed an unmodified review conclusion on the unaudited (Standalone and consolidated) financial results for the quarter and nine months ended 31st December 2024. The unmodified review report of the Statutory Auditors is being filed with the Bombay Stock Exchange and National Stock Exchange Limited. For more details on the unaudited consolidated financial results, visit 'Investor Relations section of our website at www.indofarm.in and Financial Results' in 'Corporates section of www.nseindia.com and www.bseindia.com. 3. The above unaudited (Standalone and consolidated) financial results have been prepared in accordance with the recognition and measurement principles laid down in Indian Accounting Standard 34, Interim Financial Reporting ('Ind AS 34'), prescribed under section 133 of the Companies Act, 2013 ('the Act'), and other accounting principles generally accepted in India and is in compliance with the presentation and disclosure requirements of Regulation 33 of the Listing Regulations, including relevant circulars issued by the SEBI from time to time. 4.The Company has allotted 19,00,000 Pre IPO equity shares having face value of Rs. 10 each on 16.04.2024, 30.04.2024, 24.05.2024 and 29.05.2024 at a price of Rs. 185 per share. 5.The Company has completed its Initial Public Offer (IPO) of 1,21,00,000 equity shares of face value Rs. 10 each at an issue price of Rs. 215 per share (including a share premium of Rs. 205 per share) and as a result the equity shares of the Company were listed on National Stock Exchange of India Limited (NSE) and BSE Limited (BSE) on 7th January 2025. Accordingly, the above statement of unaudited (Standalone and consolidated) financial results for the quarter ended 31st December 2024 are drawn up in accordance with the requirements of Regulation 33 of the Listing Regulations. Consequently, the result for the corresponding quarters are not given since the requirement of submission of quarterly standalone and consolidated financial results is applicable on listing of equity shares of the Company which was from quarter ended September 30, 2024. 6.The issue comprised of a fresh issue of 86,00,000 equity shares aggregating to Rs. 18490.00 lac and offer for sale of 35,00,000 equity shares by selling shareholders aggregating to Rs 7525.00 lac. The Company will provide an update on the utilisation of IPO proceeds towards the objects of the fresh issue from quarter ending March 31, 2025. 7.The certificate of Chairman and Managing Directors (CMD) and Chief Financial Officer (CFO) in terms of Regulation 33 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulation 2015 as mandate up to date in respect of the above results have been placed before the Board of Directors of the Company. 8.The unaudited (Standalone and consolidated) financial results of the Company for the quarter and nine months period ended 31st December 2024 have been filed with BSE and NSE and are also available on the Company’s website www.indofarm.in Multi segment 2024-04-01 2024-12-31 Unaudited Consolidated 2572227000.00 10094000.00 2582321000.00 1589419000.00 0.00 -140621000.00 332927000.00 187543000.00 78102000.00 392003000.00 2439372000.00 142949000.00 0.00 142949000.00 40221000.00 2369000.00 42590000.00 0.00 100359000.00 0.00 0.00 0.00 0.00 100359000.00 -47000.00 100312000.00 100359000.00 0.00 100312000.00 0.00 394516000.00 10 2.54 2.54 0.00 0.00 2.54 2.54 Other Expenses 147222000.00 Other Expenses 392003000.00 Cranes 654254000.00 NBFC 53455000.00 Others 0.00 Tractor 253974000.00 Cranes 1504530000.00 NBFC 156163000.00 Others 6978000.00 Tractor 904556000.00 961683000.00 2572227000.00 961683000.00 2572227000.00 Cranes 71297000.00 NBFC 21020000.00 Others 0.00 Tractor 28537000.00 Cranes 153860000.00 NBFC 68130000.00 Others 710000.00 Tractor 97699000.00 120854000.00 320398000.00 65292000.00 187543000.00 -1353000.00 Reportable segments are identified basis different product and service offered by the Company/Group. -10094000.00 56915000.00 142949000.00 Cranes 1396623000.00 NBFC 1343577000.00 Others 289236000.00 Tractor 2624612000.00 5654049000.00 852332000.00 6506381000.00 Cranes 311962000.00 NBFC 934451000.00 Others 1447000.00 Tractor 162818000.00 1410678000.00 1584268000.00 2994946000.00 -22000.00 -66000.00 -6000.00 -19000.00